Victory Capital Management Inc Charles River Laboratories International, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 348,276 shares of CRL stock, worth $63.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
348,276
Previous 465,694 25.21%
Holding current value
$63.9 Million
Previous $96.2 Million 28.69%
% of portfolio
0.07%
Previous 0.1%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$187.96 - $245.29 $22.1 Million - $28.8 Million
-117,418 Reduced 25.21%
348,276 $68.6 Million
Q2 2024

Aug 05, 2024
BUY
$206.39 - $268.73 $1.21 Million - $1.58 Million
5,876 Added 1.28%
465,694 $96.2 Million
Q1 2024

May 03, 2024
SELL
$203.52 - $273.43 $1.58 Million - $2.12 Million
-7,759 Reduced 1.66%
459,818 $125 Million
Q4 2023

Feb 05, 2024
BUY
$164.52 - $238.84 $15.4 Million - $22.4 Million
93,849 Added 25.11%
467,577 $111 Million
Q3 2023

Nov 06, 2023
BUY
$194.44 - $217.61 $938,367 - $1.05 Million
4,826 Added 1.31%
373,728 $73.2 Million
Q2 2023

Jul 27, 2023
SELL
$183.71 - $210.25 $738,697 - $845,415
-4,021 Reduced 1.08%
368,902 $77.6 Million
Q1 2023

May 02, 2023
BUY
$191.89 - $259.92 $6.17 Million - $8.35 Million
32,142 Added 9.43%
372,923 $75.3 Million
Q4 2022

Feb 10, 2023
BUY
$197.11 - $250.07 $974,314 - $1.24 Million
4,943 Added 1.47%
340,781 $74.2 Million
Q4 2022

Feb 09, 2023
BUY
$197.11 - $250.07 $23.9 Million - $30.3 Million
121,044 Added 56.35%
335,838 $73.1 Million
Q3 2022

Nov 02, 2022
BUY
$182.44 - $250.54 $23 Million - $31.6 Million
126,149 Added 142.31%
214,794 $42.3 Million
Q2 2022

Aug 01, 2022
SELL
$204.13 - $302.4 $20.9 Million - $31 Million
-102,554 Reduced 53.64%
88,645 $19 Million
Q1 2022

May 04, 2022
SELL
$255.51 - $362.11 $10.5 Million - $14.9 Million
-41,113 Reduced 17.7%
191,199 $53 Million
Q4 2021

Feb 07, 2022
SELL
$351.38 - $448.68 $65.2 Million - $83.3 Million
-185,621 Reduced 44.41%
232,312 $87.5 Million
Q3 2021

Nov 02, 2021
SELL
$372.64 - $458.3 $20.4 Million - $25.1 Million
-54,826 Reduced 11.6%
417,933 $172 Million
Q2 2021

Aug 03, 2021
SELL
$294.17 - $371.65 $13.5 Million - $17 Million
-45,830 Reduced 8.84%
472,759 $175 Million
Q1 2021

May 04, 2021
SELL
$249.67 - $299.48 $9.87 Million - $11.8 Million
-39,527 Reduced 7.08%
518,589 $150 Million
Q4 2020

Feb 01, 2021
SELL
$222.0 - $252.62 $18.8 Million - $21.4 Million
-84,689 Reduced 13.17%
558,116 $139 Million
Q3 2020

Nov 09, 2020
BUY
$175.56 - $226.45 $87.7 Million - $113 Million
499,581 Added 348.81%
642,805 $146 Million
Q2 2020

Aug 07, 2020
BUY
$118.84 - $189.72 $5.83 Million - $9.31 Million
49,046 Added 52.08%
143,224 $25 Million
Q1 2020

May 04, 2020
BUY
$98.9 - $178.34 $5.79 Million - $10.4 Million
58,577 Added 164.54%
94,178 $11.9 Million
Q4 2019

Feb 06, 2020
BUY
$126.05 - $152.76 $7,941 - $9,623
63 Added 0.18%
35,601 $5.44 Million
Q4 2019

Feb 04, 2020
BUY
$126.05 - $152.76 $460,208 - $557,726
3,651 Added 11.45%
35,538 $5.49 Million
Q3 2019

Nov 12, 2019
BUY
$125.07 - $143.67 $1.63 Million - $1.87 Million
13,008 Added 68.9%
31,887 $4.22 Million
Q2 2019

Aug 15, 2019
BUY
$123.4 - $148.55 $16,165 - $19,460
131 Added 0.7%
18,879 $2.68 Million
Q1 2019

May 03, 2019
SELL
$104.82 - $146.73 $28.5 Million - $39.9 Million
-271,650 Reduced 93.54%
18,748 $2.72 Million
Q4 2018

Feb 05, 2019
SELL
$105.09 - $137.23 $13 Million - $17 Million
-123,938 Reduced 29.91%
290,398 $32.9 Million
Q3 2018

Nov 01, 2018
SELL
$112.11 - $134.54 $1.07 Million - $1.28 Million
-9,501 Reduced 2.24%
414,336 $55.7 Million
Q2 2018

Aug 02, 2018
BUY
$102.37 - $117.25 $1.46 Million - $1.68 Million
14,296 Added 3.49%
423,837 $47.6 Million
Q1 2018

May 04, 2018
SELL
$98.19 - $115.2 $2.47 Million - $2.9 Million
-25,165 Reduced 5.79%
409,541 $43.7 Million
Q4 2017

Feb 01, 2018
BUY
$100.43 - $118.09 $617,945 - $726,607
6,153 Added 1.44%
434,706 $47.6 Million
Q3 2017

Oct 27, 2017
BUY
$96.72 - $109.26 $1.38 Million - $1.56 Million
14,264 Added 3.44%
428,553 $46.3 Million
Q2 2017

Aug 07, 2017
BUY
N/A
414,289
414,289 $41.9 Million

Others Institutions Holding CRL

# of Institutions
695
Shares Held
52.2M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.33B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email